|
|
Faculty
|
|
BA;
DPhil; Ohio State University
Hepatitis C Virus, Innate Immunity, Proteomics, Host-pathogen interaction.
Hepatitis C virus entry and release: Research in my laboratory has been focused on characterizing the tight junction (TJ) protein, Claudin-1, mediated HCV entry process. We are the first group to report that Claudin-1 is capable of interacting with the virus glycoproteins. We have accumulated evidence that multiple TJ proteins are assembled into a complicated molecular architecture to regulate the viral infection. The overall aim of our studies is to delineate the molecular mechanisms by which TJ proteins regulate HCV life cycle. Structural domains of TJ proteins that are required for different stages of viral lifecycle can be potentially used for drug design to stop HCV infection.
Mapping HCV interactome and secretome: This area of research was initially supported by a small institutional fund for two years, and then expanded to its current scope. We plan to map the entire HCV interacting network as well as the proteins secreted by liver cells upon HCV infection using a quantitative mass spectrometry-based proteomics approach. We believe that identified host factors contain information that is important to understanding of both HCV lifecycle and HCV pathogenesis. Our preliminary results have revealed that the critical de novo lypogenic enzyme, fatty acid synthase (FASN), was upregulated by HCV infection and secreted into supernatant. We are currently evaluating if this upregulation results in altered lipid profile. Since FASN is known to be upregulated in a number of tumors, our project has a close relevance to HCV-associated liver diseases including steatosis (accumulation of fat in liver cells) and hepatocellular carcinoma.
Immune mechanisms harnessing HIV infection: This new exploratory project is to understand if a novel group of dsRNA-editting enzymes function to introduce mutations to human immunodeficiency virus 1 (HIV-1) genome RNA. The hypothesis to be tested is that these enzymes play a pivotal role as part of the innate immune defense mechanisms to control the virus infection. Besides HIV-1, HCV and Influenza A virus will be tested as well in cell culture systems.
Systems biology of TLR signal transduction pathway: This project is funded by a NIH R21 grant for two years. The goal is to apply a newly developed mass spectrometry-based approach to systematically elucidate components of the critical innate immune signaling pathway mediated by a number of TLR receptors.
Wang, T.Y., Chuang, T, Ronni, T, Gu, S, Chen X. (2006) Fliih negatively modulates the TLR pathway. J, Immunol. 176:1355-1362.
Staff
Han, Qiwei; Research III 724 Parran Hall, 412-648-1690, qih7@pitt.edu
Students
Biswas, Nabanita 724 Parran Hall, 412-648-1690, nab31@pitt.edu
Chadwick, Sara 724 Parran Hall, 412-648-1690, slc84@pitt.edu
Postdoctoral Fellow
Liu, Shufeng 724 Parran Hall, 412-648-1690, shl57@pitt.edu
Past Lab Members
Wei Yang, PhD, Postdoctoral fellow, 2006-2008 Current position: Associate Professor, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Tsinghua University, Beijing, China.
Chao Qiu, BM, MS, Research Associate, 2006-2007 Current position: Assistant Investigator, Institutes of Biomedical Sciences at Fudan University, Shanghai, China.
Last Updated: July 10, 2008
| Home | Top of Page |
Pitt Home | Find People | Contact Us |